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Back on Track 2: The Principles of Corrective Justice for Performance Enhancing
Malpractice in Sports
Abstract
The first version of this article appeared on the Social Science Research Network more than five years
ago. At the time, Andrea Carska-Sheppard, Paul Weiler, and Jim Medford suggested an interdisciplinary
debate to bring about solutions urgently needed in the area of performance enhancing malpractice in
sports. This was before the Congressional investigations on steroid use, which brought public scrutiny to
professional sports. While our society deals (with varying success) with other types of offenses by
providing perpetrators with means of support and rehabilitation, we noted there is very little systematic
support available to athletes who are suspended for performance enhancing malpractice. The article
offered a debate on the legal model that would provide corrective justice and rehabilitation for these types
of wrongdoing. In order to create a legal model the authors turned to Professor Weiler’s proposed medical
malpractice theory and applied it to performance enhancing malpractice. The World Antidoping Agency
(WADA) has now adopted its revised Anti-Doping Code and the time has come to revisit our article and
the proposed model. What the authors found is that, despite of the passage of time, their proposal is still
timely and calls for the attention of all stakeholders. Though the new Anti-Doping Code sheds light on
various aspects of doping prosecution and education, it is silent as to the rehabilitation and assistance
provision to athletes implicated in doping. The concept of offering a systematic assistance model to the
wrongdoers relates to the morality of current and future generations, which cannot be ignored. Instead it
is time for the stakeholders to review and examine the model proposed in this article, which would assist
athletes and enhance corrective principals in doping malpractice management.
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Back on Track 2: The Principles of Corrective Justice
for Performance Enhancing Malpractice in Sports
Andrea Carska-Sheppard, Paul Weiler, Jim Medford1

I. Introduction
The first version of this article appeared on the Social Science Research Network more
than five years ago.2 At the time, we suggested an interdisciplinary debate to bring about
solutions urgently needed in the area of performance enhancing malpractice in sports. This was
before the Congressional investigations on steroid use3 which brought public scrutiny to
professional sports.
When we analyzed the issue of performance enhancing malpractice, we noted new
angles, which required analysis of, and attention to, the legal sport community and society in
general. The time had come to focus not only on the prosecution of athletes implicated in doping
offenses but to analyze their needs and provide a corrective model.
While our society deals (with varying success) with other types of offenses by providing
perpetrators with means of support and rehabilitation, we noted there is very little systematic
support available to athletes who are suspended for performance enhancing malpractice. The
article offered a debate on the legal model that would provide corrective justice and
rehabilitation for these types of wrongdoing. In order to create a legal model we have turned to
Professor Weiler’s proposed medical malpractice theory and applied it to performance enhancing
malpractice.
1

The contacts for the authors are: andrea.carska-sheppard@smithmoorelaw.com; pweiler@law.harvard.edu;
jim.medford@smithmoorelaw.com. The views expressed reflect the views of the authors alone.
2
Andrea Carska-Sheppard, Paul Weiler and Jim Medford, Back on Track: The Principles of Corrective Justice for
Performance Enhancing Malpractice in Sports, SSRN.COM (Oct. 27, 2007),
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1020302.
3
Jeff Passan, Palmeiro’s Shameful End, YAHOO! SPORTS, http://sports.yahoo.com/mlb/news?slug=jppalmeiro080106 (last visited Mar. 17, 2012).
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There is no doubt that, just like several years ago, the subject matter of performance
enhancing malpractice ignites opposing reactions. As a society, we feel morally reluctant to
offer help to those who compete unfairly. On the other hand, we recognize the fact that a doping
control system is not error-proof, and that suspended athletes need support and another chance.
The World Antidoping Agency (WADA) has now adopted its revised Anti-Doping Code
and the time has come to revisit our article and the proposed model. What we found is that,
despite of the passage of time, our proposal is still timely and calls for the attention of all
stakeholders. Though the new Anti-Doping Code sheds light on various aspects of doping
prosecution and education, it is silent as to the rehabilitation and assistance provision to athletes
implicated in doping.
As this insightful comments states “ [a]thletes who have been suspended from their sport,
even after presenting evidence that the supplements that they were taking were contaminated,
suffer tremendously. They are prevented from participating in their sport, often for a lengthy
period of time, costing them sums of money in the form of lost salary, lost prize money, and lost
endorsements.”4
The concept of offering a systematic assistance model to the wrongdoers relates to the
morality of current and future generations, which cannot be ignored. Instead, as we look forward
to London and many other sporting events, it is a good time for the stakeholders to review and
examine the model we are proposing in this article, which would assist athletes and enhance
corrective principals in doping malpractice management.

4

Howard J. Jacobs, Athlete Lawsuits Against Supplement Companies Following Positive Drug Tests, ALI-ABA
Course Materials, Course Number SP016, 1 (2009) [hereinafter Jacobs].
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II. The Strict Liability Standard for Doping
The arbitration of doping offenses is a game in which athletes never wish to participate.
However, if by choice or circumstance they take the stage in this process, they will find
themselves on complex legal grounds. The doping offenses dispute resolution system has been
criticized for its lack of fairness.5
One of the most contentious issues in sports arbitration remains the applicable standard of
proof. The root of this uncertainty stems from what standard of proof to use. Ultimately, this is
due to an apparent inability to determine the nature of doping offenses. Are these criminal,
quasi-criminal or purely civil in nature? Academics question whether this standard of proof
should fall closer to proof beyond a reasonable doubt, because doping cases are, at the least,
quasi-criminal in nature. Indeed, some may advocate for the preponderance of the evidence
standard because doping cases are private in nature.6
However, “most sport drug testing applies a strict liability standard of one form or
another.”7 What the strict liability standard means is that “that an anti-doping rule violation
occurs whenever a prohibited substance (or its metabolites or markers) is found in the bodily
specimen of an athlete, whether or not the athlete intentionally or unintentionally used a
prohibited substance or was negligent or otherwise at fault.”8 Unlike the negligence standard, the
strict liability does not distinguish between the presence or absence of fault on the part of the
defendant. As the critics pointed out, the use of strict liability goes against the notion that a
“cheater” must have requisite intent and “the system to catch cheaters, which disregards intent, is

5

Michael Straubel, Enhancing the Performance of the Doping Court: How the Court of Arbitration for Sport Can
Do Its Job Better, 36 Loy. U. Chi. L.J. 1203, 1259-1260 (2005).
6
Id.
7
Jacobs at 2.
8
Anti-Doping Glossary, WADA-AMA (Oct. 2011), http://www.wada-ama.org/en/Resources/Anti-Doping-Glossary/.
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destined to sweep up many innocent individuals in its path.”9 Despite all criticism, the strict
liability was found to be consistent with internationally recognized human rights and general
principles10 and survived the global consultation process which reviewed the original WADC
(“World Anti-Doping Code” and became part of the Revised World Anti-Doping Code which
became effective as of January 1, 2009.11
Scholars of tort law know that strict liability is at least as old as Rylands v. Fletcher.12
The proponents of the strict liability theory see it as less messy than the additional showing of
fault required in negligence cases. While negligence may appear equitable for showing the
athlete’s fault, there are practical problems in proving negligence in certain cases. “If plaintiffs
experience systematic problems in their efforts to establish fault on the part of defendants –
perhaps because of the loss or unavailability of evidence –defendants as a class will experience
insufficient levels of liability.”13 One can see that it was largely for these practical reasons why
the strict liability standard is applied in the doping offenses and it is a more efficient solution.
Some strict liability statutes (E.g. for custodians of wild and domesticated animals) are
written broadly to impose liability, irrespective of the owner’s prior knowledge, and some are
less stringent.

Likewise, in the doping world, there was an attempt to find a balance by

moderating an impact of strict liability standard of Article 2.1.1 by bringing the standards of “no

9

Jessica K. Foschi, Note: A Constant Battle: The evolving challenges in the international fight against doping in
sports, 16 Duke J. Comp. & Int'l L. 457, 485-486 (2006).
10
Id. at 477.
11
WADA Consultation Process, WADA-AMA (July 2011) http://www.wadaama.org/en/dynamic.ch2?pageCategory.id=585 (The World Anti-Doping Code was first adopted in 2003 and
became effective in 2004. The revisions to the World Anti-Doping Code that were approved by the World AntiDoping Agency Foundation Board on November 17, 2007. The revised World Anti-Doping Code became effective
on January 1, 2009).
12
Rylands v. Fletcher, 3 H. & C. 774, 159 Eng. Rep 737 (Ex. 1868).
13
JAMES A. HENDERSON, RICHARD N. PEARSON, & JOHN A. SOLICIANO, THE TORTS PROCESS 429 (Aspen
Publishers, 6th ed.) (2003).
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fault”, “no significant fault” or “negligence” on an athlete’s part at the sentencing stage. The
Commentary of the WADC to Article 2.1.1 states:
The strict liability rule for the finding of a Prohibited Substance in an Athlete's
Sample, with a possibility that sanctions may be modified based on specified
criteria, provides a reasonable balance between effective anti-doping enforcement
for the benefit of all "clean" Athletes and fairness in the exceptional circumstance
where a Prohibited Substance entered an Athlete’s system through No Fault or
Negligence or No Significant Fault or Negligence on the Athlete’s part. It is
important to emphasize that while the determination of whether the anti-doping rule
violation has occurred is based on strict liability, the imposition of a fixed period of
Ineligibility is not automatic. The strict liability principle set forth in the Code has
been consistently upheld in the decisions of CAS.14
However, as the sentencing Article 10.5 WADC, which deals with the elimination or
deduction of period of ineligibility, states it is only in “truly exceptional circumstances” and “not
in the vast majority of the cases” when this Article is operative.

As such, its impact is

constrained to very rare cases. For example, a total exoneration of the athlete would occur when
the athlete can show “that, despite all due care, he or she was sabotaged by a competitor.”15
The defenses under Article 10.5 WADC will be raised whenever the circumstances of the
cases so dictate. Whether the reduction in the ineligibility period will be applied on exceptional
bases and very rare cases will depend, amongst others, on the quality of the testing procedures.
Each year, an increasing number of athletes are tested by the WADA or by other sports bodies16,
samples are contaminated, or the failure to follow proper testing procedures17 occurs. Despite the

14

World Anti Doping Code, Art. 2.1.1 Commentary (2009), available at http://www.wadaama.org/Documents/World_Anti-Doping_Program/WADP-The-Code/WADA_Anti-Doping_CODE_2009_EN.pdf
at 19 [hereinafter World Anti Doping Code].
15
World Anti Doping Code, Art. 10.5.1 & 10.5.2 at 56-57.
16
2010 ANTI-DOPING ORGANIZATION ACTIVITY SUMMARY REPORTED BY CODE SIGNATORY ANTI-DOPING
ORGANIZATIONS (2010), available at http://www.wadaama.org/Documents/Resources/Statistics/ADO_Statistics/WADA_2010_ADO_Statistics_Report.pdf
17
The CAS panel accepted that the supplemental contamination was likely the cause of the positive urine test. See
Knauss v. FIS, CAS, A/847 (Aust.– Switz.) (2005) (It took a professor of law and four third-year law students, all
members of the Sports Law Clinic to succeed in representing a professional athlete whose doping test results were
shown not be accurate and that scientific procedures were not followed by a testing lab. “Those factors led to a
reduction of the otherwise applicable two-year suspension to 18 months.”).
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best efforts to keep up with research on chemicals, steroids and highly speculative gene doping18,
the performance enhancing control system for false negatives is not fully reliable.19

III. Consequences of Doping Offenses
The WADC deals in great detail examining determination of culpability. It addresses
issues of the sanctions for the individual and other stakeholders, the need for education to
establish an environment that is strongly conducive to doping-free sport, but there is no guidance
provided as to what, if any, assistance the individuals implicated in the doping offenses get. In
terms of the consequences of doping offenses, the WADC sets them out in regards to
individuals20, the teams (e.g. target testing)21 and sanctions against sporting bodies.22 It also deals
with the sanctions applicable to athlete support personnel to competent authorities. It provides
for the mechanism to determine the period of ineligibility and the athlete’s status during period
of ineligibility.
An ineligible athlete cannot participate in a training camp, exhibition or practice
organized by his or her National Federation or a club, which is a member of that Federation.23 It
is also made explicit by the rules that “some or all sport-related financial support or other sportrelated benefits received by such Person athlete will be withheld by Signatories, Signatories'
member organizations and governments.”24

18

Paul D. Trumble, “Knickel” and Dime Issues: An Unexplored Loophole In New York’s Genetic Discrimination
Statute And The Viability of Genetic Testing In the Sports Employment Context, 70 Alb. L. Rev. 771 (2007).
19
Ben Sellenger, Genetic Testing: The Future of Athlete Selection?, 2 Va. Sports & Ent. L.J. 207, 213 (2003)
(warning of the "arbitrary application" of genetic testing in sports).
20
World Anti Doping Code, Art. 11 at 77.
21
World Anti Doping Code. Art. 12 at 78. .
22
World Anti Doping Code, Art. 10.10.1 at 74.
23
World Anti Doping Code, Art. 10.10.2 at 75-76.
24
World Anti Doping Code, Commentary Art. 10.10.3 at 75.
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The athletes who are suspended may lose the support network that was created for them.
A suspension rendered the athlete ineligible to have access to the training facilities of the USOC
Training Centers or other programs and activities of the USOC, including grants and awards of
employment.25 One of the clearer statements what happens to the suspended athletes after the
adjudication, admission or acceptance of the doping offense is provided by the United States
Olympic Committee (“USOC) Anti-Doping Polices in Annex C.

26

It is made explicit that the

athlete loses the direct athlete support and, after the conclusion of the suspension, he/she will
have to re-qualify for athlete support programs (e.g., attain appropriate rank, etc.).

The

suspended athletes cannot be considered for a tuition grant during any period of suspension but if
an athlete loses only the result, the tuition grant is maintained. First time violators of Section
10.3 of the World Anti-Doping Code keep their access to the Olympic Training Center and
Olympic Training Sites as well as the Olympic training center residence.
First time violators keep their other USOC benefits, such as career consulting, access to
the Athlete Service Center, media services, personal development programs, resource library
access, sport science and coaching. What is less clear is to what extent the Athlete marketing
services (including access to sponsor programs) are provided because, as stated on the website,
“[p]articipation in the OJOP program and sponsor programs will also be dependent on employer
or sponsor views” 27 which may result in a rather arbitrary standard. Elite Athletes, who are first
time violators of Section 10.3 of the World Anti-Doping Code, do not lose the health insurance

25

United States Anti-Doping Agency v. Mark Hainline, A.A.A. Case No. 30 190 00789 05 (2005) (Gans, Brunet,
Witherspoon, Arb.).
26
Annex C To USOC National Anti-Doping Policies, TEAM USA,
http://www.teamusa.org/resources/teamusanet/athlete-services/usoc-suspension-of-benefits-policy (last visited Feb.
8, 2012).
27
Id.
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The Elite Athlete program offers eligible athletes a level of base

support by offering a program of health and major medical insurance for designated Elite
Athletes in order to minimize the out-of-pocket expenses incurred by insured athletes for costs of
medical care. 29
As is specified by the USOC under the World Anti-Doping Code, NGBs (“National
Governing Bodies”), as members of a Code signatory (the USOC), must engage in the same or
similar suspensions of benefits and access as the USOC. NGBs are to adopt policies similar to
those adopted by the USOC within this policy, subject to USOC approval. There is very little
systematic support provided to the athletes.
Beyond the institutional impact, there are personal consequences to the athletes, who
suffer emotionally and economically as a result of allegations/being implicated in the doping
malpractice. In some, but not all cases, the arbitration costs are born by the athletes’ Olympic
committee or federation.30 Those who have to finance their arbitration and lose leave the process
morally condemned and financially depleted, facing the prospect of temporary or permanent
unemployment, usually with very modest transferable skills.

To support their living, only a

small group can rely on their personal savings and/or endorsement insurance. The rest are left, to
large extent, on their own to cope with moral stigma, little or no transferable skills, and no clear
possibility for making a comeback.

28

Id.
Elite Athlete Health Insurance Information (EAHI), TEAM USA,
http://www.teamusa.org/resources/teamusanet/athlete-services/elite-athlete-health-insurance-information-eahi (last
visited Feb. 8, 2012).
30
Id.
29
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IV. Turning for Assistance
Doping raises concerns not only in sports but in a social context as well.31 Numerous
international instruments (i.e., the World Anti-Doping Code, the Athlete Outreach Model,

32

the

Lausanne Declaration on Doping in Sport,33 and the International Convention Against Doping in
Sport34) were developed to prevent and detect the problem of doping, but now we need to move a
step further and recognize that the current doping control system needs not only to punish and
deter but must also play a role in the rehabilitation of the athletes. Unlike other wrongdoers,
suspended athletes have no predictable support network and no counselors “on hand.”
One of the forms of risk management in law and economics is insurance. It provides
transfer of risk from one entity to another in exchange for the payment. This raises question how
the insurance industry deals with the performance enhancing malpractice in sports. As we will
show, the insurance companies have “strong policy reasons for limiting coverage in case of some
intentional harm.”35 As such, how the individual insurers deal with the insurance contracts and
how they can provide source of assistance for the athletes who have been involved in doping is a
grey area.
To start with, there are only a small number of companies that specialize in insurance
products for athletes, such as K&K Insurance providers and Lloyds of London. Given the high
risks associated with sports and the susceptibility of the athletes to various types of injuries, this
31

George W. Bush, President of the United States of America, State of the Union Address at a Joint Session of
Congress (Jan. 20, 2004), transcript available at http://www.washingtonpost.com/wpsrv/politics/transcripts/bushtext_012004.html (last visited Mar. 17, 2012). In the 2004 State of the Union Address, it
was mentioned that the use of performance-enhancing drugs, even in a minority of elite athletes, sets a dangerous
example for the millions of young Americans.
32
Doping Lusanne Declaration (Feb. 4 1999), available at
http://www.la84foundation.org/OlympicInformationCenter/OlympicReview/1999/OREXXVI25/OREXXVI25g.pdf
33
Adopted by the World Conference on Doping in Sport 4 February 1999, Lausanne, Switzerland.
34
Council of Europe Anti-Doping Convention No. 135, Nov. 16, 1989., S. TREATY DOC. NO. 110-14, E.T.S. 135;
see also John R. Crook, United States Supports New UNESCO Instruments on Doping in Sports and on Bioethics;
Votes Against New Convention on Cultural Diversity, 100 AM. J. INT’L L. 229 (2006).
35
TOM BAKER, INSURANCE, LAW AND POLICY 478 (Aspen Publishers, 1st ed. 2003).
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low concentration of insurance product providers is understandable. The insurance coverage for
athletes usually carries a high price tag. In order to get coverage, the athletes must undergo
intensive medical evaluations by both their teams and the insurance companies to determine the
likelihood of having a predisposition to a particular illness, but even the athletes who are healthy
and very successful have to pay enormous amounts to insure their contracts. 36 Other than
contract insurance, there are number of insurance products specifically designed for athletes and
the sports industry; i.e.., Accidental Death and Dismemberment, Temporary Total Disability,
Permanent Total Disability, Kidnap and Ransom, Image Protection, Critical Asset Protection,
Contractual Bonus, Insurance programs for elite athletes, future earnings against injury, Personal
Accident and Team Stop Loss. Most of these insurance products are not specific about the
coverage for athletes who are charged with being under the influence of drugs or narcotics that
are not lawfully available.
Further, it is also unclear which substances or methods listed on the WADA’s Prohibited
List carry with themselves criminal penalties. 37 This is country-specific but creates difficulty for
the insurers. On the one hand there is an athlete who was charged by performance enhancing
malpractice by an international body of law, on the other hand there is an insurance contract
governed by chosen law and usually silent on exclusions for the performance enhancing
malpractice.

The current process seems to be thus based more on the case-by-case

determination. 38

36

For example, Daniel Alfredsson would have to pay more than $1 million to insure his five-year, $32.5-million US
deal with the Senators to play back home in Sweden.
37
World Anti-Doping Agency, The World Anti-Doping Code: The 2006 Prohibited List (Sept. 19, 2005), available
at http://www.internationalgolffederation.org/MemberOnly/pdf/2%20-%202006%20Prohibited%20List.pdf
(WADA’s Prohibited List includes the substances and methods that are prohibited: 1) at all times; 2) in competition;
and 3) in particular sporting events. It also references so-called specialized substances).
38
The rumors of doping by Lance Armstrong were enough for SCA, a Texas Insurance company, to refuse to pay
the six-time Tour de France winner the $5M bonus that became due to him when he broke the record for victories.
At the initial stage, all the evidence the SCA had against him was circumstantial speculation by the authors of an
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This lack of interest and systematic assistance should raise serious concerns. These
individuals are treated differently than other vulnerable members of society who can rely on a
support network provided by their community or their professional organizations.

V. Professor Weiler’s Radically Moderate Correlative Model and Doping Malpractice
In order to balance this imbalanced situation for these athletes in comparison with other
wrongdoers, we need to inquire as to what can be done to bring these athletes back on track. To
better extrapolate this situation, we need to analyze it from the corrective justice point of view.
Citing Aristotle, Professor Weinrib contrasts corrective justice with distributive justice.39
While distributive justice is concerned with “proportional equality, in which all participants in
the distribution receive their shares according to their respective merits under the criterion in
question,” the corrective justice “features the maintenance and restoration of the notional
equality with which the parties enter the transaction.”

40

It links the doer and sufferer of an

injustice in terms of their correlative positions. 41
When devising a reform model for medical malpractice, Professor Weiler adopted what
he calls a radically moderate approach for examining the correlative positions of all the parties
involved. In our first Back on Track

42

article, we introduced his reform proposal and examined

unauthorized biography in France. Ultimately, the SCA had to retract its premature exclusion and paid the bonus.
However, this example shows how allegations of performance enhancement can prompt insurers to take adverse
actions against athletes who have never been sanctioned. William Fotheringham, Insurers withhold $5m Tour bonus
for Armstrong, THE GUARDIAN (Sept. 23, 2004),
http://sport.guardian.co.uk/tourdefrance2004/story/0,14667,1310624,00.html.
39
Ernest J. Weinrib, Corrective Justice in a Nutshell, 52 U. Toronto L.J. 349 (2002).
40
Id.
41
Id. at 351.
42
Andrea Carska-Sheppard, Paul Weiler and Jim Medford, Back on Track: The Principles of Corrective Justice for
Performance Enhancing Malpractice in Sports, SSRN (Oct. 27, 2007),
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1020302.
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whether any elements of his model can be transposed into solving correlative issues in
performance enhancing malpractice.
The analysis of Professor Weiler’s model included assessment of the “vulnerable
stakeholders in the medical malpractice system,” as well as the proposition that traditional
personal liability of individual physicians needs to be replaced by a new full-blown enterprise
liability of health care organizations. It was followed by the proposal that it was necessary for
the responsible organization in the medical malpractice context to create an internal peer review
committee as one of its quality assurance programs. Lastly, the model stated that to bring
malpractice reform even further would require a radical move from fault to no-fault liability,
which would treat injured patients in the same fashion as injured nurses.
Summing up, three pillars of Professor Weiler’s proposed medical malpractice reform are
enterprise liability of the health care organization for the wrongdoing of doctors, a peer review
system implemented by the health care organization, and no-fault liability for the injured
patients. These pillars redefine the respective position of the parties and would restore the
notional equality with which the parties enter the transaction when they seek treatment. We had
then examined whether any of these principles can be transposed to performance enhancing
malpractice and, as we will show, it is feasible to apply two out of three elements in this new
context.
Unlike in medical malpractice where the injuries are often the result of the high-risk
medical profession in which the doctors commit the wrong unintentionally; the athletes usually,
but not always, resort to taking performance-enhancing substances by their own choice.
Unfortunately, the current testing is not risk free and innocent victims can become implicated in
the doping scandals. Obviously, the testing has to keep up with and preferably keep ahead of
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science but, given these risks, it is feasible that other bodies, such as the sports organizations,
should step in to bear the risk of the process, which is not free of wrongful convictions. Though
admittedly the wrongful convictions are rare, the effects on wrongly convicted individuals are
profound. These are reasons why enterprise liability, which was also introduced in the medical
malpractice model, should apply in the present context.
The theory of enterprise liability, according to Gregory C. Keating, “asserts “that (1)
accident costs should be internalized by the activity responsible for them; and (2) accident costs
should be dispersed and distributed among the participants in that activity. This idea can be
incarnated by strict liability in tort, but it can also be incarnated in other ways. Indeed, enterprise
liability first appears in Worker’s Compensation schemes enacted early in the twentieth century.
Enterprise liability in tort generally involves imposing strict liability on injurers, but its aim can
also be affected by mandatory loss insurance. Compulsory loss insurance spreads an activity’s
accident cost among all the potential victims of an activity, each of whom pays a premium to
spread his or her share of the risk.”43
However, this enterprise liability model would differ from the medical malpractice in that
it would continue applying the current strict liability regime rather than the no-fault regime. The
enterprise liability would require sports organizations to underwrite compulsory loss insurance in
order to generate funds aimed for professional rehabilitation of athletes.

VI. Feasibility of the Proposed Model
Naturally, the issue arises whether this well-intended model is subject to abuse by
repeated wrongdoers and it raises concern about the risk of anti-selection. In the insurance
world, anti-selection occurs when high-risk individuals purchase more insurance than those with
43
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normal-risk exposure. This could lead to an overall premium increase in order for insurers to
protect themselves. 44
We believe that though there is such a risk, the loss of endorsements, faith and the moral
stigma associated with doping are factors that will give disincentive for abuse of this model. The
policy principle, which we seek to achieve, is to protect innocent victims from wrongful
convictions and “put back on track” a broad population of athletes. Clearly, in order to achieve
the deterrence aspect, the endorsement insurance should not be available to repeated wrongdoers.
In addition, to give a disincentive for athletes to rely on the insurance and engage in
performance enhancing malpractice, each sport federation could set up an internal peer review
committee. The funds would be payable to the committee in trust for the athlete who is in the
process of rehabilitation. This system will provide impetus for the sports organization to be
more vigilant and internally manage/suppress any suspicion of the doping activity at its root.
To be eligible for this income, the athlete will need to cooperate with the peer review
committee, truly disclose the circumstances of the doping offense and spend a number of hours
in community service.

The peer review committee will be constituted by two members

appointed by the federation and one member designated by the athlete and will also provide
emotional support and monitor the come-back of the athlete.
In addition, individual sport federations/organizations may also choose to negotiate a
short-term disability insurance that would pay for living expenses during the suspension, but this
would have to be explored separately. It also seems to be the case, that if we want the athletes
and sports organizations to be covered by certain insurance policies, we need to steer away from

44

Christopher M. Keefer, Bridging the Gap Between Life Insurer and Consumer in the Genetic Testing Era: The RF
Proposal, 74 Ind. L.J. 1375, 1384-1385 (1999).

2012]

BACK ON TRACK 2

151

classifying the performance enhancing malpractice as criminal or quasi-criminal, and treat them
more like “sui generis” offenses.
In addition, the insurance companies can assume a more active role and have more
control over the process. The time may be ripe for insurers to reach beyond their traditional roles
in relation to sports. “Over the years, insurance institutions have been a significant force in the
development and dissemination of harm-reducing technologies and practices.”

45

This

involvement of insurance companies in testing and developing new technologies did not happen
randomly, but this trend is rooted in the core function of insurance institutions, which is harm
prevention. “It is not uncommon for insurance companies to test and rate the crashworthiness of
cars or to establish the underwriter’s labs to test materials for resistance to fire and other
hazards.”46
As such, the insurers who would underwrite specialized insurance for the sports
organizations/federations to cover athletes’ expenses during their doping suspensions, may be
more motivated to become involved in risk prevention – developing more accurate doping
control systems. This would bring added value, not only for the parties involved, but also to
society in general because more precise testing would reduce the risk of wrongful suspensions.
However, even if the insurers and sports federations would be willing to consider such a
new model, we need to ask ourselves whether such a system would not be contradictory to the
deterrence objective of the doping suspensions.
First, this support model will not be available to permanently suspended athletes who are
repeat offenders because this type of relief only provides a temporary means of support. In
addition, the athletes who will benefit from this assistance will ultimately have to pay their dues

45
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back when they reenter the competition and negotiate their insurance policies. As part of
negotiating the insurance policy, they will have to disclose their history of doping, which will
result in paying higher insurance premiums.

VII. Conclusion
As we are gearing up for the 2012 Summer London Olympics and future international
sporting events, the organizers of theses events spend great effort and resources to educate the
athletes by launching “win clean campaigns”47 and other measures. The issue of assisting
athletes who engage or are accused of engaging in performance enhancing malpractice is also a
moral question about whether our society wants to assist individuals who presumably compete
unfairly, in order to gain advantage over others and receive undeserving glory. There is an
aspect of paternalism in providing a helping hand to these individuals. However, this proposed
corrective model is not imposed or mandated. It is up to each sport’s organization/federation to
consider its applicability to their particular sport, culture and region and adopt it in conjunction
with the specialty insurance providers, which would best serve their needs.
Our societies seek to provide a system of support and rehabilitation for all types of
morally reprehensible forms of conduct. There is no reason for not providing it for those who
engage in performance enhancing malpractice. There are many athletes who regret their bad
decisions and wish “to come back on track”, compete, inspire others who are outside of the field
of sports, and also hope for a second chance.

47
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